Pages that link to "Q39477943"
Jump to navigation
Jump to search
The following pages link to Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella (Q39477943):
Displaying 50 items.
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (Q22241905) (← links)
- Extended-spectrum beta-lactamases: a clinical update (Q24534999) (← links)
- Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat (Q24550671) (← links)
- Combating antimicrobial resistance: policy recommendations to save lives (Q24632857) (← links)
- Opinion: the clinical use of selective digestive decontamination (Q24795736) (← links)
- Optimizing antibiotic therapy in the intensive care unit setting (Q24796204) (← links)
- Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy (Q24808798) (← links)
- Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit (Q24813204) (← links)
- Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones (Q26828604) (← links)
- Acinetobacter baumannii: an emerging opportunistic pathogen (Q26830893) (← links)
- Optimizing antimicrobial therapy in critically ill patients (Q26999905) (← links)
- Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship (Q28068503) (← links)
- Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use (Q28299749) (← links)
- A population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatments (Q28539364) (← links)
- Antimicrobial stewardship: philosophy versus practice. (Q30367226) (← links)
- Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli (Q30661849) (← links)
- Antimicrobial consumption data from pharmacy and nursing records: how good are they? (Q30988681) (← links)
- Extended-spectrum beta-lactamases and clinical outcomes: current data (Q33236875) (← links)
- Molecular epidemiology of multidrug resistant extended spectrum beta-lactamase producing Klebsiella pneumoniae at a Jamaican hospital, 2000-2004 (Q33527134) (← links)
- HIGH PREVALENCE OF MULTI-DRUG RESISTANT KLEBSIELLA PNEUMONIAE IN A TERTIARY TEACHING HOSPITAL IN WESTERN KENYA. (Q33623407) (← links)
- A review of the role of antibiotic policies in the control of antibiotic resistance (Q33647952) (← links)
- How do you choose antibiotic treatment? (Q33655055) (← links)
- Reversibility of antibiotic resistance (Q33667524) (← links)
- Antibiotic resistance: a current perspective (Q33693954) (← links)
- Antibiotic use in humans and bacterial resistance. (Q33745245) (← links)
- Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients (Q33826293) (← links)
- The microbial genetics of antibiotic cycling (Q33827956) (← links)
- Strategies for study of the role of cycling on antimicrobial use and resistance (Q33827964) (← links)
- Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit? (Q33873338) (← links)
- Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient (Q33913195) (← links)
- Pharmacoeconomics of pneumonia (Q33913201) (← links)
- Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management (Q33928647) (← links)
- Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization (Q33939115) (← links)
- The pharmacist's role in promoting optimal antimicrobial use. (Q33942876) (← links)
- Antimicrobial resistance--pharmacological solutions (Q33961778) (← links)
- Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut (Q33964309) (← links)
- Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18 (Q33980456) (← links)
- Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections (Q34026758) (← links)
- Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients (Q34052619) (← links)
- Antimicrobial use and bacterial resistance (Q34069797) (← links)
- Emerging issues in antibiotic resistance in blood-borne infections (Q34078706) (← links)
- Antimicrobial stewardship programs in health care systems (Q34097674) (← links)
- Quality measures of antimicrobial drug use. (Q34118023) (← links)
- Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics (Q34213605) (← links)
- Antimicrobial resistance in the chronically critically ill patient (Q34227358) (← links)
- Antimicrobial stewardship (Q34228050) (← links)
- Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae (Q34249399) (← links)
- The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection (Q34325764) (← links)
- Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients (Q34336456) (← links)
- Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals (Q34340879) (← links)